Cupron supports its partners through ongoing dialogue with, collaboration with and reporting to key regulatory agencies around the world. This commitment allows Cupron to (1) secure additional claims to the marketplace regarding the effectiveness of Cupron Technology, and (2) expand the use of Cupron technology into new applications. Our primary regulatory programs include the Environmental Protection Agency (EPA) and the Food and Drug Administration (FDA) in the United States. In addition, we are expanding our efforts with other regulatory agencies around the world.
To date, Cupron has 4 registrations with the EPA that permit the use of Cupron Technology across all cosumer applications. Currently these registrations permit anti-odor, product protection, and 3 "public health" claims: anti-dustmite, specific anti-fungal and antibacterial efficacy that relates to solid surfaces. Cupron also has an FDA listing for Cupron Enhanced anti-odor hospital bed linens and a European CE Mark for the use of a Cupron Enhanced anti-viral mask effective against H1N1 and avian influenza viruses.
For cosmetic applications, Cupron has achieved recognition by the International Nomenclature of Cosmetics Index ("INCI"), where Cupron Copper Oxide has been recognized as a trade name and Cuprous Oxide recognized as official INCI name.